Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Interleukin 1 receptor (IL-1R) is a cytokine receptor that binds interleukin-1 (IL-1), playing a central role in mediating immune and inflammatory responses. There are two main forms of the receptor: type I (IL-1RI) and type II (IL-1RII). Type I IL-1 receptor transmits the pro-inflammatory effects of IL-1. Type II IL‑1 receptor functions mainly as a decoy or suppressor by competing for ligand binding but does not signal. Signaling through type I interleukin–1 receptors regulates thymocyte proliferation, B cell development, production of cytokines, stress responses, inflammatory responses, sleep regulation, and appetite control. Defects or dysregulation in this pathway contribute to various autoimmune diseases.
Receptor antagonism or ligand sequestration to block IL-1 signaling
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 1 Receptor (IL-1R).